Ruthenium tetrazene complexes bearing glucose moieties on their periphery: Synthesis, characterization, and in vitro cytotoxicity
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F60461373%3A22310%2F20%3A43923763" target="_blank" >RIV/60461373:22310/20:43923763 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/67985858:_____/20:00533067 RIV/61388955:_____/20:00533067 RIV/00209805:_____/20:00078468 RIV/00216208:11310/20:10420989
Výsledek na webu
<a href="https://onlinelibrary.wiley.com/doi/10.1002/aoc.5896" target="_blank" >https://onlinelibrary.wiley.com/doi/10.1002/aoc.5896</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1002/aoc.5896" target="_blank" >10.1002/aoc.5896</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Ruthenium tetrazene complexes bearing glucose moieties on their periphery: Synthesis, characterization, and in vitro cytotoxicity
Popis výsledku v původním jazyce
Ruthenium tetrazene complexes with general formula [Cp*RuCl(1,4-R2N4)] (Cp* = η5-C5Me5), where R = benzyl (1), 2-fluorobenzyl (2), β-d-glucopyranosyl-unprotected (3a) and acyl-protected (3b–d), 2-acetamido-β-d-glucopyranosyl-unprotected (4a) and acyl-protected (4b–d), propyl-β-d-glucopyranoside-unprotected (5a), and O-acetylated (5b), were synthesized and characterized using nuclear magnetic resonance and electrospray ionization–mass spectrometry. In addition, the molecular structure of 3b was determined using X-ray crystallography. The cytotoxicity of complexes against ovarian (A2780, SK-OV-3) and breast (MDA-MB-231) cancer cell lines and noncancerous cell line HEK-293 was evaluated and compared to cisplatin activity. The carbohydrate-modified complexes bearing acyl-protecting groups exhibited higher efficacy (in low micromolar range) than unprotected ones, where the most active 4d was superior to cisplatin up to five times against all investigated cancer cell lines; however, no significant selectivity was achieved. The complex induced apoptotic cell death at low micromolar concentrations (0.5 μM for A2780 and HEK293; 2 μM for SK-OV-3 and MDA-MB-231). © 2020 John Wiley & Sons, Ltd.
Název v anglickém jazyce
Ruthenium tetrazene complexes bearing glucose moieties on their periphery: Synthesis, characterization, and in vitro cytotoxicity
Popis výsledku anglicky
Ruthenium tetrazene complexes with general formula [Cp*RuCl(1,4-R2N4)] (Cp* = η5-C5Me5), where R = benzyl (1), 2-fluorobenzyl (2), β-d-glucopyranosyl-unprotected (3a) and acyl-protected (3b–d), 2-acetamido-β-d-glucopyranosyl-unprotected (4a) and acyl-protected (4b–d), propyl-β-d-glucopyranoside-unprotected (5a), and O-acetylated (5b), were synthesized and characterized using nuclear magnetic resonance and electrospray ionization–mass spectrometry. In addition, the molecular structure of 3b was determined using X-ray crystallography. The cytotoxicity of complexes against ovarian (A2780, SK-OV-3) and breast (MDA-MB-231) cancer cell lines and noncancerous cell line HEK-293 was evaluated and compared to cisplatin activity. The carbohydrate-modified complexes bearing acyl-protecting groups exhibited higher efficacy (in low micromolar range) than unprotected ones, where the most active 4d was superior to cisplatin up to five times against all investigated cancer cell lines; however, no significant selectivity was achieved. The complex induced apoptotic cell death at low micromolar concentrations (0.5 μM for A2780 and HEK293; 2 μM for SK-OV-3 and MDA-MB-231). © 2020 John Wiley & Sons, Ltd.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
10401 - Organic chemistry
Návaznosti výsledku
Projekt
—
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2020
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Applied Organometallic Chemistry
ISSN
0268-2605
e-ISSN
—
Svazek periodika
34
Číslo periodika v rámci svazku
11
Stát vydavatele periodika
US - Spojené státy americké
Počet stran výsledku
12
Strana od-do
—
Kód UT WoS článku
000544622600001
EID výsledku v databázi Scopus
2-s2.0-85087296067